Trending...
- Roofman USA Expands Roofing Services Across Michigan, Adding Key Locations - 169
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes - 162
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025 - 155
Contact: Ryan Jarvi 517-599-2746Agency: Attorney General
November 17, 2020
LANSING — Michigan Attorney General Dana Nessel joined a coalition of 22 attorneys general in a letter to the U.S. Department of Health & Human Services (HHS) and its National Institutes of Health (NIH) urging them to reject recent recommendations made by the Trump administration's NIH Human Fetal Tissue Ethics Advisory Board (Board).
The Board's recommendation would withhold federal funding for fetal tissue research grant proposals, putting limits on research into possible treatments and therapies for various health conditions, including COVID-19. The recommendation comes after a two-year campaign by the Trump administration to block federally funded research using fetal tissue as well as an executive order to ban the research.
"While leading scientists are encouraging the use of fetal tissue research to develop treatments for the COVID-19 pandemic, the Trump administration is attempting to withhold critical funding for this important work," Nessel said. "Our country has been hard hit by this pandemic – this recommendation by the Board would effectively hinder advances in finding a treatment for this devastating virus. President Trump himself was treated for COVID with Remdesivir, a drug developed through fetal tissue research – why shouldn't every American have that opportunity?"
More on Michimich.com
Fetal tissue has been an essential part of scientific and medical advances that have saved millions of lives in the United States and across the globe. Fetal tissue was used in the research that led to the vaccines for poliovirus, rubella, measles and rabies. It remains a crucial part of vital biomedical research.
In its letter, the coalition argues the Board was not fairly balanced in terms of viewpoint, as two-thirds of its members are on record opposing abortion, fetal tissue or both. The Board's proceedings also lacked transparency. All of its meetings were in closed session except for one virtual meeting held for less than an hour. The attorneys general urge NIH Director Francis S. Collins and HHS Secretary Alex M. Azar II to use their authority to reject the Board's recommendations and maintain federal funding for research projects using fetal tissue that have already been recommended for funding.
In sending the letter, Attorney General Nessel joins the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia, Wisconsin, and the District of Columbia.
A copy of the letter is available here.
November 17, 2020
LANSING — Michigan Attorney General Dana Nessel joined a coalition of 22 attorneys general in a letter to the U.S. Department of Health & Human Services (HHS) and its National Institutes of Health (NIH) urging them to reject recent recommendations made by the Trump administration's NIH Human Fetal Tissue Ethics Advisory Board (Board).
The Board's recommendation would withhold federal funding for fetal tissue research grant proposals, putting limits on research into possible treatments and therapies for various health conditions, including COVID-19. The recommendation comes after a two-year campaign by the Trump administration to block federally funded research using fetal tissue as well as an executive order to ban the research.
"While leading scientists are encouraging the use of fetal tissue research to develop treatments for the COVID-19 pandemic, the Trump administration is attempting to withhold critical funding for this important work," Nessel said. "Our country has been hard hit by this pandemic – this recommendation by the Board would effectively hinder advances in finding a treatment for this devastating virus. President Trump himself was treated for COVID with Remdesivir, a drug developed through fetal tissue research – why shouldn't every American have that opportunity?"
More on Michimich.com
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
- Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
- DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
Fetal tissue has been an essential part of scientific and medical advances that have saved millions of lives in the United States and across the globe. Fetal tissue was used in the research that led to the vaccines for poliovirus, rubella, measles and rabies. It remains a crucial part of vital biomedical research.
In its letter, the coalition argues the Board was not fairly balanced in terms of viewpoint, as two-thirds of its members are on record opposing abortion, fetal tissue or both. The Board's proceedings also lacked transparency. All of its meetings were in closed session except for one virtual meeting held for less than an hour. The attorneys general urge NIH Director Francis S. Collins and HHS Secretary Alex M. Azar II to use their authority to reject the Board's recommendations and maintain federal funding for research projects using fetal tissue that have already been recommended for funding.
In sending the letter, Attorney General Nessel joins the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia, Wisconsin, and the District of Columbia.
A copy of the letter is available here.
0 Comments
Latest on Michimich.com
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Nora Knople Honored as a Leader and Innovator in Hypnosis
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- Comerica Incorporated Names Kristina Janssens Senior Executive Vice President and Chief Risk Officer
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation